Amikacin Export Market Intelligence: India's 327 Suppliers Shipping to 104 Countries — TransData Nexus 2026

Q: Who are the top amikacin exporters from India?

The top amikacin exporters from India are: 1. AVET LIFESCIENCES PRIVATE LIMITED — $3.2M (15.2% market share); 2. LINCOLN PHARMACEUTICALS LTD — $2.6M (12.2% market share); 3. AJANTA PHARMA LIMITED — $1.7M (7.9% market share); 4. EMCURE PHARMACEUTICALS LIMITED — $1.5M (7.1% market share); 5. LYKA LABS LIMITED — $1.1M (5.3% market share). Together they account for 47.7% of India's total amikacin export value.

Q: What is the total export value of amikacin from India?

The total export value of amikacin from India is $21.1M USD, recorded across 1,657 shipment transactions from 327 active exporters to 104 destination countries. The average shipment value is $12.7K.

Q: Which countries import amikacin from India?

India exports amikacin to 104 countries worldwide. The top importing countries are: IRAQ (23.2% share, $4.9M), UNITED STATES (17.5% share, $3.7M), PAKISTAN (12.6% share, $2.7M), TURKEY (8.4% share, $1.8M), UNITED ARAB EMIRATES (6.1% share, $1.3M). These five markets account for 67.7% of total export value.

Q: What is the HS code for amikacin exports from India?

The primary HS code for amikacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of amikacin exports from India?

The average unit price for amikacin exports from India is $5.67 USD per unit, with prices ranging from $0.01 to $708.12 depending on formulation, packaging, and order volume. The total market is valued at $21.1M across 1,657 shipments.

Q: Which ports handle amikacin exports from India?

The primary ports for amikacin exports from India are SAHAR AIR CARGO ACC (INBOM4) (11.3% of shipments), SAHAR AIR (10.9% of shipments), NHAVA SHEVA SEA (INNSA1) (7.1% of shipments), JNPT/ NHAVA SHEVA SEA (4.6% of shipments), MUNDRA SEA (4.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of amikacin?

India is one of the world's leading exporters of amikacin due to its large base of 327 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports amikacin to 104 countries, demonstrating 53% global market coverage.

Q: What certifications do Indian amikacin exporters need?

Indian amikacin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import amikacin from India?

There are 514 registered buyers importing amikacin from India, spread across 104 countries. The repeat buyer rate is 53.1%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top amikacin supplier from India?

AVET LIFESCIENCES PRIVATE LIMITED is the leading amikacin exporter from India with a market share of 15.2% and total export value of $3.2M across 47 shipments. The top 5 suppliers together control 47.7% of total export value.

Suresh Sormare

Amikacin

India Pharmaceutical Trade Intelligence

$21.1M327 Suppliers104 CountriesHS 30049099

ExportsIndia → IRAQ23.2%India → UNITED STATES17.5%

ImportsIRAQ → India$16.1K UNITED STATES → India$1.5K

#1 Supplier: AVET LIFESCIENCES

Amikacin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Amikacin to the World

Between 2022 and 2026, India exported $21.1M worth of amikacin across 1,657 verified shipments to 104 countries — covering 53% of world markets in the Advanced Antibiotics segment. The largest destination is IRAQ (23.2%). AVET LIFESCIENCES PRIVATE LIMITED leads with a 15.2% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Amikacin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Amikacin export data snapshot — $21.1M · 327 exporters · 104 countriesTransData Nexus · Indian Customs Data

Top Amikacin Exporters from India

327 active exporters · Ranked by export value

View all 327 →

Top Amikacin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	AVET LIFESCIENCES PRIVATE LIMITED	$3.2M	47	1	15.2%
2	LINCOLN PHARMACEUTICALS LTD

Top Countries Importing Amikacin from India

104 destination markets · Ranked by import value

All 104 countries →

Top Countries Importing Amikacin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	IRAQ	$4.9M	23.2%
2	UNITED STATES	$3.7M	17.5%
3	PAKISTAN	$2.7M	12.6%
4	TURKEY	$1.8M	8.4%
5	UNITED ARAB EMIRATES	$1.3M	6.1%
6	UNITED KINGDOM	$1.3M	6.0%
7	AFGHANISTAN	$651.3K	3.1%
8	PHILIPPINES	$518.6K	2.5%
9	CANADA	$507.0K	2.4%
10	TURKMENISTAN	$331.8K	1.6%

IRAQ is India's largest amikacin export destination, absorbing 23.2% of total exports worth $4.9M. The top 5 importing countries — IRAQ, UNITED STATES, PAKISTAN, TURKEY, UNITED ARAB EMIRATES — together account for 67.7% of India's total amikacin export value. The remaining 99 destination countries collectively receive the other 32.3%, indicating a well-diversified global distribution network spanning all major continents.

Who Supplies Amikacin to India?

3 origin countries · Total import value: $17.6K

India imports amikacin from 3 countries with a combined import value of $17.6K. The largest supplier is IRAQ ($16.1K, 1 shipments), followed by UNITED STATES and ARGENTINA. All values are from Indian Customs (DGFT) import records.

Countries Supplying Amikacin to India — Ranked by Import Value
#	Origin Country	Import Value (USD)	Shipments	Share
1	IRAQ	$16.1K	1	91.2%
2	UNITED STATES	$1.5K	3	8.8%
3	ARGENTINA	$8	1	0.0%

IRAQ is the largest supplier of amikacin to India, accounting for 91.2% of total import value. Click any country to see detailed supplier and buyer data for that import corridor.

Amikacin — Export Intelligence Video

Visual overview of India's amikacin import and export market — top suppliers, destinations, pricing, and trade routes

This video covers India's amikacin pharmaceutical import and export market — $21.1M in total trade, 327 verified manufacturers, and 104 destination countries. Data sourced from Indian Customs (DGFT) shipment records.

Regulatory Landscape — Amikacin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

In the United States, Amikacin is approved for various indications, including severe bacterial infections. The FDA's Orange Book lists multiple approved Abbreviated New Drug Applications (ANDAs) for Amikacin, reflecting its established presence in the market. Notably, in October 2018, the FDA approved Arikayce, a liposomal inhalation suspension of Amikacin, for the treatment of Mycobacterium avium complex (MAC) lung disease in adults with limited treatment options. This approval was granted under the Limited Population Pathway for Antibacterial and Antifungal Drugs (LPAD pathway), emphasizing the drug's importance in addressing unmet medical needs. The substantial number of active Indian exporters (327) supplying Amikacin to the U.S. market underscores the critical role of Indian pharmaceutical companies in meeting American healthcare demands.

2EU & UK Regulatory Framework

Within the European Union, Amikacin is authorized for use in treating severe infections caused by susceptible strains of bacteria. The European Medicines Agency (EMA) has evaluated Amikacin-containing products, including Arikayce liposomal, which received marketing authorization in October 2020 for the treatment of non-tuberculous mycobacterial (NTM) lung infections caused by MAC in adults with limited treatment options. This approval highlights the EMA's commitment to facilitating access to essential medicines for rare conditions. Manufacturers exporting Amikacin to the EU and UK must comply with Good Manufacturing Practice (GMP) standards as outlined by the EMA and the UK's Medicines and Healthcare products Regulatory Agency (MHRA), ensuring product quality and patient safety.

3WHO Essential Medicines & Global Standards

Amikacin is included in the World Health Organization's (WHO) Model List of Essential Medicines, underscoring its critical role in treating severe bacterial infections. The 24th edition of the list, published in 2025, categorizes Amikacin under Access group antibiotics, recommended as a first-choice treatment for high-risk febrile neutropenia and severe pyelonephritis or prostatitis. This inclusion reflects the global consensus on Amikacin's importance in essential healthcare. Additionally, Amikacin is recognized in major pharmacopoeias, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP), ensuring standardized quality and efficacy across different regions.

4India Regulatory Classification

In India, Amikacin is classified under Schedule H of the Drugs and Cosmetics Rules, indicating that it is a prescription-only medication. This classification mandates that Amikacin be dispensed only with a valid prescription from a registered medical practitioner, ensuring its appropriate use. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines, including Amikacin, to make them affordable and accessible. Manufacturers intending to export Amikacin are required to obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT), ensuring compliance with national export regulations.

5Patent & Exclusivity Status

The patent landscape for Amikacin includes several key patents, particularly concerning specialized formulations. For instance, Insmed Incorporated holds multiple U.S. patents for Arikayce, a liposomal inhalation suspension of Amikacin, with expirations extending up to May 2035. These patents provide market exclusivity for specific formulations and uses, while the base compound, Amikacin, is available for generic production, allowing for broader access and competition in the market.

6Recent Industry Developments

In March 2023, the European Medicines Agency (EMA) conducted a Periodic Safety Update Report Single Assessment (PSUSA) for Amikacin, leading to variations in product information to enhance safety and efficacy profiles. This assessment underscores the ongoing regulatory vigilance to ensure patient safety.

In October 2025, the EMA updated the marketing authorization for Arikayce liposomal, reflecting continued regulatory oversight and commitment to addressing rare pulmonary infections. These developments highlight the dynamic regulatory environment surrounding Amikacin and the importance of staying abreast of changes to maintain compliance and market access.

In summary, Amikacin's regulatory landscape is multifaceted, involving stringent oversight in major markets such as the United States, European Union, United Kingdom, and India. Its inclusion in the WHO Model List of Essential Medicines and recognition in major pharmacopoeias affirm its global significance. Indian pharmaceutical companies play a pivotal role in the global supply chain, necessitating adherence to diverse regulatory requirements to ensure continued market access and compliance.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Global Price Benchmark — Amikacin

Retail & reference prices across 9 markets vs. India FOB export price of $5.67/unit

Global Price Benchmark for Amikacin across major pharmaceutical markets
Market	Price (USD/unit)	Currency	Reference
United States	$4.45 per 500 mg vial	USD	According to the World Health Organization (WHO) report "WHO/CDS/CPC/TB/99.262" published in November 1999, the price of Amikacin in the United States was $8.90 per 1 g vial. While this data is historical, it provides a reference point for pricing.
United Kingdom	Data not available	GBP	Specific pricing data for Amikacin 500 mg vials in the United Kingdom is not readily available from government or international sources.
Germany	Data not available	EUR	Specific pricing data for Amikacin 500 mg vials in Germany is not readily available from government or international sources.

Supply Chain Risk Assessment — Amikacin

API sourcing, concentration risk, storage requirements, and current alerts

MEDIUM RISK

1API Sourcing & Raw Material Dependency

Amikacin, an aminoglycoside antibiotic, is primarily produced in India, which has established itself as a significant manufacturer of Active Pharmaceutical Ingredients (APIs). However, the production of Amikacin APIs is heavily reliant on Key Starting Materials (KSMs) imported from China. This dependency poses a substantial risk, as any disruption in the supply of these KSMs can directly impact API production. Notably, 41% of KSMs used in U.S.-approved APIs are solely sourced from China, highlighting the concentration risk in the supply chain.

Recent events have underscored this vulnerability. In July 2024, environmental regulations led to the shutdown of several Chinese chemical plants, causing significant supply chain disruptions for Indian pharmaceutical manufacturers. This resulted in increased prices and shortages of essential APIs, including those for antibiotics like Amikacin.

2Supplier Concentration & Single-Source Risk

The export data from TransData Nexus indicates that the top five Indian exporters of Amikacin account for 47.7% of the total export value, with AVET LIFESCIENCES PRIVATE LIMITED alone contributing 15.2%. This concentration suggests a moderate risk, as disruptions affecting these key suppliers could significantly impact global Amikacin availability.

To mitigate such risks, the Indian government has implemented the Production Linked Incentive (PLI) scheme, aiming to boost domestic production of critical APIs and reduce reliance on imports. In October 2024, two greenfield plants were inaugurated under this scheme to manufacture essential molecules used in antibiotics, marking a significant step towards self-sufficiency.

Access Complete Amikacin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 1,657 transactions across 104 markets.

Request Demo View Pricing

Frequently Asked Questions — Amikacin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top amikacin exporters from India?

The leading amikacin exporters from India are AVET LIFESCIENCES PRIVATE LIMITED, LINCOLN PHARMACEUTICALS LTD, AJANTA PHARMA LIMITED, and 12 others. AVET LIFESCIENCES PRIVATE LIMITED leads with 15.2% market share ($3.2M). The top 5 suppliers together control 47.7% of total export value.

What is the total export value of amikacin from India?

The total export value of amikacin from India is $21.1M, recorded across 1,657 shipments from 327 active exporters to 104 countries. The average shipment value is $12.7K.

Which countries import amikacin from India?

India exports amikacin to 104 countries. The top importing countries are IRAQ (23.2%), UNITED STATES (17.5%), PAKISTAN (12.6%), TURKEY (8.4%), UNITED ARAB EMIRATES (6.1%), which together account for 67.7% of total export value.

What is the HS code for amikacin exports from India?

The primary HS code for amikacin exports from India is 30049099. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Amikacin

Amikacin

Top Amikacin Exporters from India

Top Countries Importing Amikacin from India

Who Supplies Amikacin to India?

Quick Facts

Related Advanced Antibiotics

Related Analysis

Need Details?

Amikacin — Export Intelligence Video

Regulatory Landscape — Amikacin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Global Price Benchmark — Amikacin

Supply Chain Risk Assessment — Amikacin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Amikacin Trade Intelligence

Frequently Asked Questions — Amikacin Exports from India

Who are the top amikacin exporters from India?

What is the total export value of amikacin from India?

Which countries import amikacin from India?

What is the HS code for amikacin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

India Cost Advantage

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of amikacin exports from India?

Which ports handle amikacin exports from India?

Why is India a leading exporter of amikacin?

What certifications do Indian amikacin exporters need?

How many buyers import amikacin from India?

What is the market share of the top amikacin exporter from India?

Analysis Methodology